RAS ubiquitylation modulates effector interactions

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics, 2009. CA Cancer J. Clin. 2009;59(4):225-249. https://doi.org/10.3322/caac.20006
   PubMed Web of Science ®Google Scholar
• Hobbs GA, Der CJ, Rossman KL. RAS Isoforms and Mutations in Cancer at a Glance. J. Cell Sci. 2016;129:1287-1292. https://doi.org/10.1242/jcs.182873
   PubMed Web of Science ®Google Scholar
• Bos JL, Rehmann H, Wittinghofer A. Review GEFs and GAPs : Critical Elements in the Control of Small G Proteins. Cell. 2007;129(5):865-877. https://doi.org/10.1016/j.cell.2007.05.018
   PubMed Web of Science ®Google Scholar
• Du X, Sprang SR. Transition State Structures and the Roles of Catalytic Residues in GAP-Facilitated GTPase of Ras as Elucidated by (18)O Kinetic Isotope Effects. Biochemistry 2009;48(21):4538-4547. https://doi.org/10.1021/bi802359b
   PubMed Web of Science ®Google Scholar
• Scheffzek K, Ahmadian MR, Wittinghofer A. GTPase-Activating Proteins: Helping Hands to Complement an Active Site. Trends Biochem. Sci. 1998;23(7):257-262. https://doi.org/10.1016/S0968-0004(98)01224-9
   PubMed Web of Science ®Google Scholar
• Vigil D, Cherfils J, Rossman KL, Der CJ. Ras Superfamily GEFs and GAPs: Validated and Tractable Targets for Cancer Therapy?. Nat. Rev. Cancer. 2010;10(12):842-857. https://doi.org/10.1038/nrc2960
   PubMed Web of Science ®Google Scholar
• Ahearn IM, Haigis K, Bar-sagi D, Philips MR. Regulating the Regulator : Post-Translational Modification of RAS. Nat. Publ. Gr. 2012;13(1):39-51
   Google Scholar
• Shen Y, Lange O, Delaglio F, Rossi P, Aramini JM, Liu G, Eletsky A, Wu Y, Singarapu KK, Lemak A et al., Consistent Blind Protein Structure Generation from NMR Chemical Shift Data. Proc. Natl. Acad. Sci. U. S. A. 2008;105(12):4685-4690. https://doi.org/10.1073/pnas.0800256105
   PubMed Web of Science ®Google Scholar
• Yang MH, Laurent G, Bause AS, Spang R, German N, Haigis MC, Haigis KM. HDAC6 and SIRT2 Regulate the Acetylation State and Oncogenic Activity of Mutant K-RAS. Mol. Cancer Res. 2013;11(September):1072-1078. https://doi.org/10.1158/1541-7786.MCR-13-0040-T
   PubMedGoogle Scholar
• Ahearn IM, Haigis K, Bar-Sagi D, Philips MR. Regulating the Regulator: Post-Translational Modification of RAS. Nat. Rev. Mol. Cell Biol. 2012;13(1):39-51. https://doi.org/10.1038/nrm3255
   Web of Science ®Google Scholar
• Sasaki AT, Carracedo A, Locasale JW, Anastasiou D, Takeuchi K, Kahoud ER, Haviv S, Asara JM, Paolo P, March LCC et al., Ubiquitination of K-Ras Enhances Activation and Facilitates Binding to Select Downstream Effectors. Sci. Signal. 2011;4(163):ra13. https://doi.org/10.1126/scisignal.2001518
   PubMed Web of Science ®Google Scholar
• Baker R, Lewis SSM, Sasaki AT, Wilkerson EM, Locasale JW, Cantley LC, Kuhlman B, Dohlman HG, Campbell SL. Site-Specific Monoubiquitination Activates Ras by Impeding GTPase-Activating Protein Function. Nat. Struct. Mol. Biol. 2013;20(1):46-52. https://doi.org/10.1038/nsmb.2430
   PubMed Web of Science ®Google Scholar
• Hobbs GA, Gunawardena HP, Baker R, Campbell SL. Site-Specific Monoubiquitination Activates Ras by Impeding GTPase-Activating Protein Function. Small GTPases. 2013;4(3):186-192. https://doi.org/10.4161/sgtp.26270
   PubMedGoogle Scholar
• Scheffzek K, Ahmadian MR, Kabsch W, Wiesmu L, Lautwein A, Schmitz F, Wittinghofer A. The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants. Science. 1997;277(5324):333-338. https://doi.org/10.1126/science.277.5324.333
   PubMed Web of Science ®Google Scholar
• Merkley N, Barber KR, Shaw GS. Ubiquitin Manipulation by an E2 Conjugating Enzyme Using a Novel Covalent Intermediate. J. Biol. Chem. 2005;280(36):31732-31738. https://doi.org/10.1074/jbc.M505205200
   PubMed Web of Science ®Google Scholar
• Zakaria M, Brown PR. High-Performance Liquid Column Chromatography of Nucleotides, Nucleosides and Bases. J. Chromatogr. 1981;226:267-290. https://doi.org/10.1016/S0378-4347(00)86062-4
   PubMed Web of Science ®Google Scholar
• Herrmann C, Horn G, Spaargaren M, Wittinghofer A. Differential Interaction of the Ras Family GTP-Binding Proteins H-Ras, Rap1A, and R-Ras with the Putative Effector Molecules Raf Kinase and Ral-Guanine Nucleotide Exchange Factor. J. Biol. Chem. 1996;271(12):6794-6800. https://doi.org/10.1074/jbc.271.12.6794
   PubMed Web of Science ®Google Scholar
• Block C, Janknecht R, Herrmann C, Nassar N, Wittinghofer A. Quantitative Structure-Activity Analysis Correlating Ras/Raf Interaction in Vitro to Raf Activation in Vivo. Nat. Struct. Biol. 1996;3(3):244-251. https://doi.org/10.1038/nsb0396-244
   PubMedGoogle Scholar
• Lenzen C, Cool RH, Prinz H, Wittinghofer A. Kinetic Analysis by Fluorescence of the Interaction between Ras and the Catalytic Domain of the Guanine Nucleotide Exchange Factor Cdc25 Mm †. Biochemistry 1998;2960(97):7420-7430.
   Google Scholar
• Eccleston JF, Moore KJ, Morgan L, Skinner RH, Lowe P N. Kinetics of Interaction between Normal and Proline 12 Ras and the GTPase-Activating Proteins, p120-GAP and Neurofibromin. The Significance of the Intrinsic GTPase Rate in Determining the Transforming Ability of Ras. J. Biol. Chem. 1993;268(36):27012-27019
   PubMed Web of Science ®Google Scholar
• Gideon P, John J, Frech M, Lautwein A, Clark R, Scheffler JE, Wittinghofer A. Mutational and Kinetic Analyses of the GTPase-Activating Protein (GAP)-p2l Interaction : The C-Terminal Domain of GAP Is Not Sufficient for Full Activity. Mol. Cell. Biol. 1992;12(5):2050-2056. https://doi.org/10.1128/MCB.12.5.2050
   PubMed Web of Science ®Google Scholar
• Kiel C, Serrano L, Herrmann C. A Detailed Thermodynamic Analysis of Ras/effector Complex Interfaces. J. Mol. Biol. 2004;340(5):1039-1058. https://doi.org/10.1016/j.jmb.2004.05.050
   PubMed Web of Science ®Google Scholar
• Wohlgemuth S, Kiel C, Krämer A, Serrano L, Wittinghofer F, Herrmann C. Recognizing and Defining True Ras Binding Domains I: Biochemical Analysis. J. Mol. Biol. 2005;348(3):741-758. https://doi.org/10.1016/j.jmb.2005.02.048
   PubMed Web of Science ®Google Scholar
• Kiel C, Serrano L. Structure-Energy-Based Predictions and Network Modelling of RASopathy and Cancer Missense Mutations. Mol. Syst. Biol. 2014;10:727. https://doi.org/10.1002/msb.20145092
   PubMed Web of Science ®Google Scholar
• Pacold ME, Suire S, Perisic O, Lara-Gonzalez S, Davis CT, Walker EH, Hawkins PT, Stephens L, Eccleston JF, Williams RL. Crystal Structure and Functional Analysis of Ras Binding to Its Effector Phosphoinositide 3-Kinase Gamma. Cell. 2000;103:931-943. https://doi.org/10.1016/S0092-8674(00)00196-3
   PubMed Web of Science ®Google Scholar
• Kiel C, Filchtinski D, Spoerner M, Schreiber G, Kalbitzer H R, Herrmann C. Improved Binding of Raf to Ras.GDP Is Correlated with Biological Activity. J. Biol. Chem. 2009;284(46):31893-31902. https://doi.org/10.1074/jbc.M109.031153
   PubMed Web of Science ®Google Scholar
• Ford B, Boykevisch S, Zhao C, Kunzelmann S, Bar-Sagi D, Herrmann C, Nassar N. Characterization of a Ras Mutant with Identical GDP- and GTP-Bound Structures. Biochemistry. 2009;48(48):11449-11457. https://doi.org/10.1021/bi901479b
   PubMed Web of Science ®Google Scholar
• Nakhaeizadeh H, Amin E, Nakhaei-rad S, Dvorsky R, Ahmadian MR. The RAS-Effector Interface : Isoform-Specific Differences in the Effector Binding Regions. Public Libr. Sci. One. 2016;11(12):1-20.
   Web of Science ®Google Scholar
• Hurley JH, Lee S, Prag G. Ubiquitin-Binding Domains. Biochem. J. 2006;399(3):361-372. https://doi.org/10.1042/BJ20061138
   PubMed Web of Science ®Google Scholar
• Fisher RD, Wang B, Alam SL, Higginson DS, Robinson H, Sundquist WI, Hill CP. Structure and Ubiquitin Binding of the Ubiquitin-Interacting Motif. J. Biol. Chem. 2003;278(31):28976-28984
   Google Scholar